Skip to main content
logo
Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
113.27
+4.78 (4.41%)
Aug 12, 2026, 3:50 PM EDT - Market open

Dianthus Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1.94.0712.475.656.42-
Revenue Growth
-50.60%-67.35%120.63%-11.92%--
Gross Profit
1.94.0712.475.656.42-
Operating Income
-217.84-177.93-101.86-48.17-29.71-74.69
Net Income
-192.25-162.34-84.97-43.56-28.48-71.14
Earnings Per Share
-4.15-4.20-2.55-8.45-32.57-15.01
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
886.81404.3275.24173.7275.49176.93
Total Debt
1.291.391.490.590.790
Net Cash (Debt)
885.53402.91273.75173.1374.7176.93
Net Cash Growth
245.83%47.18%58.12%131.76%-57.78%18.87%
Net Cash Per Share
18.9610.438.2233.6085.45202.56

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-155.38-129.06-78.18-36.86-29.07-59.53
Capital Expenditures
-0.33-0.21-0.11-0.11-0.14-1.26
Free Cash Flow
-155.71-129.27-78.29-36.97-29.21-60.8
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%100.00%100.00%-
Operating Margin
-11441.40%-4369.67%-816.87%-852.34%-462.91%-
Pretax Margin
-10094.43%-3986.67%-681.39%-770.61%-443.76%-
Profit Margin
-10097.00%-3986.67%-681.39%-770.61%-443.76%-
FCF Margin
-8177.99%-3174.68%-627.79%-654.12%-455.18%-

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
3260.88437.4354.4027.270.86-